Back
Day Range
$18.24
$19.31
52-Week Range
$14.69
$30.81
Volume
897,357
50D / 200D Avg
$18.84
/
$22.58
Prev Close
$18.51
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -11.7 | 0.3 |
| P/B | 2.7 | 2.9 |
| ROE % | -21.7 | 3.7 |
| Net Margin % | -33.6 | 3.8 |
| Rev Growth 5Y % | 1.0 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$21.95
+15.7%
Low: $13.00
High: $30.75
Forward P/E
822.7
Forward EPS
$0.02
EPS Growth (est.)
+0.0%
Est. Revenue
260 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.21
$1.03 – $1.33
|
410 M | 2 |
| FY2029 |
$0.61
$0.18 – $1.44
|
340 M | 6 |
| FY2028 |
$0.57
$0.25 – $0.86
|
320 M | 5 |
Key Takeaways
Revenue grew 0.96% annually over 5 years — modest growth
Debt/Equity of 0.11 — conservative balance sheet
Negative free cash flow of -40.05M
Revenue growth is decelerating — 1Y growth trails 5Y average by 24.68%
Capital efficient — spends only 2.43% of revenue on capex
Growth
Revenue Growth (5Y)
0.96%
Revenue (1Y)-23.72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-21.70%
ROIC-8.99%
Net Margin-33.60%
Op. Margin-19.16%
Safety
Debt / Equity
0.11
Current Ratio4.55
Interest Coverage0.00
Valuation
P/E Ratio
-11.68
P/B Ratio2.73
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -23.72% | Revenue Growth (3Y) | -13.82% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0.96% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 239.44M | Net Income (TTM) | -80.45M |
| ROE | -21.70% | ROA | -17.43% |
| Gross Margin | 73.88% | Operating Margin | -19.16% |
| Net Margin | -33.60% | Free Cash Flow (TTM) | -40.05M |
| ROIC | -8.99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.11 | Current Ratio | 4.55 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.68 | P/B Ratio | 2.73 |
| P/S Ratio | 3.92 | PEG Ratio | -0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 939.26M | Enterprise Value | 824.46M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 239.44M | 313.90M | 322.42M | 284.39M | 230.47M |
| Net Income | -80.45M | -20.21M | 21.35M | 39.67M | 27.51M |
| EPS (Diluted) | -1.62 | -0.41 | 0.43 | 0.80 | 0.50 |
| Gross Profit | 176.90M | 239.58M | 252.65M | 223.38M | 178.64M |
| Operating Income | -45.87M | -12.61M | 28.10M | 43.80M | 33.34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 461.62M | 509.52M | 488.69M | 418.82M | 345.78M |
| Total Liabilities | 117.44M | 112.19M | 102.74M | 82.71M | 87.22M |
| Shareholders' Equity | 344.18M | 397.34M | 385.95M | 336.11M | 258.56M |
| Total Debt | 38.35M | 38.74M | 35.83M | 31.04M | 32.06M |
| Cash & Equivalents | 153.15M | 144.16M | 183.04M | 86.48M | 199.71M |
| Current Assets | 311.55M | 367.94M | 365.27M | 311.72M | 271.41M |
| Current Liabilities | 68.50M | 70.31M | 65.04M | 51.72M | 48.80M |